For senolytic research rather than AMPK or mitochondrial signaling, compare against FOXO4-DRI
In addition to its effects on GH release, MK-677 also activates the secretion of insulin-like growth factor 1 (IGF-1), which plays a role in cell growth, replication, and repair
In light of this emerging viewpoint, perhaps type 2 diabetes should be approached as yet another mitochondrial disorder that requires carnitine supplementation
Through downregulating monocyte chemoattractant protein-1 expression, semaglutide treatment, an FDA-approved GLP-1 RA medicine targeting Type II diabetes mellitus (T2DM) (Christou et al., 2019), inhibited monocyte migration and infiltration from the circulatory system to inflammatory regions (Pontes-da-Silva et al., 2022)
therefore, conclusive statement about the mechanism of their execution cannot be stated